Sonoma Pharmaceuticals Inc
SNOA3.105USD
+0.115+3.85%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
5.07MMarket Cap
LossP/E TTM
More Details of Sonoma Pharmaceuticals Inc Company
Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.
Company Info
Ticker SymbolSNOA
Company nameSonoma Pharmaceuticals Inc
IPO dateJan 26, 2007
CEOMs. Amy Trombly
Number of employees168
Security typeOrdinary Share
Fiscal year-endJan 26
Address5445 Conestoga Court, Suite 150
CityBOULDER
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code80301
Phone18007599305
Websitehttps://sonomapharma.com/
Ticker SymbolSNOA
IPO dateJan 26, 2007
CEOMs. Amy Trombly
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Bruce Thornton
Mr. Bruce Thornton
Chief Operating Officer, Executive Vice President, Corporate Secretary
Chief Operating Officer, Executive Vice President, Corporate Secretary
7.72K
-0.01%
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Bruce Thornton
Mr. Bruce Thornton
Chief Operating Officer, Executive Vice President, Corporate Secretary
Chief Operating Officer, Executive Vice President, Corporate Secretary
7.72K
-0.01%
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Human Care
12.08M
84.54%
Animal Care
1.65M
11.57%
Service and Royalty
556.00K
3.89%
By RegionUSD
Name
Revenue
Proportion
Europe
5.52M
38.65%
Latin America
2.96M
20.73%
United States
2.61M
18.27%
Asia
2.32M
16.22%
Rest of the world
875.00K
6.12%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Human Care
12.08M
84.54%
Animal Care
1.65M
11.57%
Service and Royalty
556.00K
3.89%
Shareholding Stats
Updated: Sat, Jul 26
Updated: Sat, Jul 26
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Geode Capital Management, L.L.C.
1.02%
HRT Financial LP
0.72%
Thornton (Bruce)
0.47%
Trombly (Amy Moss)
0.47%
The Vanguard Group, Inc.
0.41%
Other
96.91%
Shareholders
Shareholders
Proportion
Geode Capital Management, L.L.C.
1.02%
HRT Financial LP
0.72%
Thornton (Bruce)
0.47%
Trombly (Amy Moss)
0.47%
The Vanguard Group, Inc.
0.41%
Other
96.91%
Shareholder Types
Shareholders
Proportion
Individual Investor
1.28%
Investment Advisor
1.25%
Investment Advisor/Hedge Fund
1.02%
Hedge Fund
0.09%
Research Firm
0.06%
Other
96.30%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
39
60.82K
4.60%
-8.84K
2025Q1
40
54.41K
3.31%
-8.75K
2024Q4
40
41.45K
2.57%
-24.32K
2024Q3
41
49.08K
3.40%
+9.77K
2024Q2
40
43.04K
3.61%
+17.90K
2024Q1
38
20.55K
2.85%
-9.28K
2023Q4
36
27.53K
4.02%
+7.17K
2023Q3
35
18.63K
7.25%
-6.00K
2023Q2
37
18.70K
7.42%
+4.13K
2023Q1
36
7.93K
3.54%
-8.20K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Geode Capital Management, L.L.C.
16.80K
1.02%
+16.80K
--
Mar 31, 2025
HRT Financial LP
11.84K
0.72%
+11.84K
--
Mar 31, 2025
Thornton (Bruce)
7.72K
0.47%
+2.68K
+53.16%
Jun 21, 2024
Trombly (Amy Moss)
7.68K
0.47%
+2.68K
+53.58%
Jun 21, 2024
The Vanguard Group, Inc.
6.67K
0.41%
--
--
May 31, 2025
Dvonch (Jerome J)
4.23K
0.26%
+2.68K
+172.90%
Jun 21, 2024
UBS Financial Services, Inc.
1.85K
0.11%
-15.58K
-89.37%
Mar 31, 2025
Tower Research Capital LLC
1.45K
0.09%
-960.00
-39.88%
Mar 31, 2025
Dal (Poggetto John)
910.00
0.06%
+910.00
--
Jun 20, 2024
Citi Investment Research (US)
811.00
0.05%
+811.00
--
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Date
Type
Ratio
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
